Increasing evidence of efficacy and safety of GLP-1 RAs may encourage health care professionals to recognize that obesity is now a treatable serious chronic disease and motivate patients to re‐engage with weight loss when previous attempts have been ineffective or unsustainable. The gene discussed is GLP1R; the disease is obesity disorder.